US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.050
  • -0.010-0.94%
Close Sep 27 16:00 ET
  • 1.100
  • +0.050+4.76%
Post 20:02 ET
120.97MMarket Cap-2763P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
10.67%64.98M
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
Operating revenue
0.03%58.47M
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.82%58.46M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
Cost of revenue
14.17%28.37M
104.97%34.59M
126.86%158.99M
495.46%84.57M
-7.18%32.7M
120.34%24.85M
80.09%16.87M
21.69%70.08M
17.33%14.2M
65.57%35.23M
Gross profit
8.10%36.61M
172.95%42.48M
-30.30%98.25M
-77.67%6.96M
310.84%41.87M
-30.70%33.87M
-69.33%15.56M
-47.59%140.96M
-49.16%31.15M
-83.36%10.19M
Operating expense
-16.50%57.12M
2.03%85M
-24.23%301.45M
-8.21%75.86M
-18.50%73.87M
-26.35%68.41M
-36.73%83.31M
-25.33%397.84M
-18.02%82.64M
-3.59%90.64M
Selling and administrative expenses
-22.10%35.17M
15.01%56.53M
-3.26%192.02M
-7.70%49.49M
7.57%48.22M
-11.96%45.14M
0.82%49.15M
16.95%198.48M
7.13%53.62M
12.29%44.83M
Research and development costs
-5.64%21.96M
-16.64%28.47M
-45.11%109.44M
-9.14%26.37M
-44.01%25.65M
-44.08%23.27M
-58.81%34.15M
-45.10%199.36M
-42.83%29.02M
-15.30%45.81M
Operating profit
40.63%-20.51M
37.23%-42.53M
20.90%-203.2M
-33.81%-68.91M
60.22%-32.01M
21.52%-34.54M
16.29%-67.75M
2.64%-256.88M
-30.21%-51.49M
-145.37%-80.45M
Net non-operating interest income expense
46.35%-5.33M
-14.46%-11.12M
-24.84%-40.54M
-13.15%-10.62M
-36.18%-10.27M
-51.11%-9.94M
-8.28%-9.71M
-41.44%-32.47M
-62.01%-9.39M
-30.65%-7.54M
Non-operating interest expense
-46.35%5.33M
14.46%11.12M
24.84%40.54M
13.15%10.62M
36.18%10.27M
51.11%9.94M
8.28%9.71M
41.44%32.47M
62.01%9.39M
30.65%7.54M
Other net income (expense)
699.13%12.92M
8,957.64%156.52M
327.88%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
127.92%1.73M
-748.06%-2.4M
621.56%2.01M
4,363.33%1.34M
Special income (charges)
--11.46M
--153.65M
--0
--0
--0
--0
--0
---6.22M
--0
--0
-Less:Other special charges
--12.63M
----
----
----
----
----
----
--6.22M
--0
----
-Gain on sale of business
--24.09M
--153.65M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-9.28%1.47M
66.03%2.87M
43.09%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
5,300.00%1.73M
1,450.53%3.82M
621.56%2.01M
4,363.33%1.34M
Income before tax
69.86%-12.92M
235.85%102.88M
18.33%-238.27M
-35.30%-79.65M
53.81%-40.02M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
Income tax
0
0
-380K
0
-380K
0
0
0
0
0
Net income
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
Net income continuous Operations
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
Minority interest income
Net income attributable to the parent company
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
Basic earnings per share
77.55%-0.11
194.79%0.91
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
Diluted earnings per share
77.55%-0.11
186.46%0.83
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 10.67%64.98M137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M
Operating revenue 0.03%58.47M137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.82%58.46M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M
Cost of revenue 14.17%28.37M104.97%34.59M126.86%158.99M495.46%84.57M-7.18%32.7M120.34%24.85M80.09%16.87M21.69%70.08M17.33%14.2M65.57%35.23M
Gross profit 8.10%36.61M172.95%42.48M-30.30%98.25M-77.67%6.96M310.84%41.87M-30.70%33.87M-69.33%15.56M-47.59%140.96M-49.16%31.15M-83.36%10.19M
Operating expense -16.50%57.12M2.03%85M-24.23%301.45M-8.21%75.86M-18.50%73.87M-26.35%68.41M-36.73%83.31M-25.33%397.84M-18.02%82.64M-3.59%90.64M
Selling and administrative expenses -22.10%35.17M15.01%56.53M-3.26%192.02M-7.70%49.49M7.57%48.22M-11.96%45.14M0.82%49.15M16.95%198.48M7.13%53.62M12.29%44.83M
Research and development costs -5.64%21.96M-16.64%28.47M-45.11%109.44M-9.14%26.37M-44.01%25.65M-44.08%23.27M-58.81%34.15M-45.10%199.36M-42.83%29.02M-15.30%45.81M
Operating profit 40.63%-20.51M37.23%-42.53M20.90%-203.2M-33.81%-68.91M60.22%-32.01M21.52%-34.54M16.29%-67.75M2.64%-256.88M-30.21%-51.49M-145.37%-80.45M
Net non-operating interest income expense 46.35%-5.33M-14.46%-11.12M-24.84%-40.54M-13.15%-10.62M-36.18%-10.27M-51.11%-9.94M-8.28%-9.71M-41.44%-32.47M-62.01%-9.39M-30.65%-7.54M
Non-operating interest expense -46.35%5.33M14.46%11.12M24.84%40.54M13.15%10.62M36.18%10.27M51.11%9.94M8.28%9.71M41.44%32.47M62.01%9.39M30.65%7.54M
Other net income (expense) 699.13%12.92M8,957.64%156.52M327.88%5.47M-106.42%-129K68.26%2.25M265.01%1.62M127.92%1.73M-748.06%-2.4M621.56%2.01M4,363.33%1.34M
Special income (charges) --11.46M--153.65M--0--0--0--0--0---6.22M--0--0
-Less:Other special charges --12.63M--------------------------6.22M--0----
-Gain on sale of business --24.09M--153.65M--------------0--0------------
Other non- operating income (expenses) -9.28%1.47M66.03%2.87M43.09%5.47M-106.42%-129K68.26%2.25M265.01%1.62M5,300.00%1.73M1,450.53%3.82M621.56%2.01M4,363.33%1.34M
Income before tax 69.86%-12.92M235.85%102.88M18.33%-238.27M-35.30%-79.65M53.81%-40.02M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M
Income tax 00-380K0-380K00000
Net income 69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M
Net income continuous Operations 69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M
Minority interest income
Net income attributable to the parent company 69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M
Basic earnings per share 77.55%-0.11194.79%0.9132.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11
Diluted earnings per share 77.55%-0.11186.46%0.8332.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data